Hiroto Izumi Selected Research

UDP-N-acetylgalactosamine polypeptide N-acetylgalactosaminyltransferase 6

1/2017	GalNAc-T6 in the relationship with invasion ability of endometrial carcinomas and prognostic significance.
1/2017	Expression of N-Acetylgalactosaminyltransferase-6 Is Related to Expression of Cell Adhesion Molecules in Endometrial Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroto Izumi Research Topics

Disease

53	Neoplasms (Cancer) 01/2021 - 03/2002
11	Lung Neoplasms (Lung Cancer) 01/2020 - 12/2003
7	Breast Neoplasms (Breast Cancer) 01/2020 - 08/2003
7	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2003
6	Inflammation (Inflammations) 01/2022 - 01/2008
4	Pneumonia (Pneumonitis) 04/2021 - 01/2015
4	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 04/2010
4	Adenocarcinoma 01/2020 - 04/2002
4	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 04/2002
4	Hypoxia (Hypoxemia) 01/2018 - 10/2008
4	Carcinoma (Carcinomatosis) 12/2013 - 01/2003
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 12/2019
3	Carcinogenesis 01/2017 - 10/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2010 - 07/2007
2	Hypersensitivity (Allergy) 01/2022 - 01/2014
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2021
2	Asthma (Bronchial Asthma) 01/2022 - 01/2021
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2022 - 01/2021
2	Idiopathic Pulmonary Fibrosis 12/2019 - 04/2016
2	Melanoma (Melanoma, Malignant) 01/2019 - 06/2009
2	Thyroid Neoplasms (Thyroid Cancer) 10/2017 - 12/2013
2	Squamous Cell Carcinoma of Head and Neck 01/2016 - 12/2015
2	Ovarian Neoplasms (Ovarian Cancer) 04/2015 - 02/2012
2	Lymphatic Metastasis 01/2014 - 02/2007
2	Pancreatic Neoplasms (Pancreatic Cancer) 05/2010 - 06/2009
2	Adenocarcinoma of Lung 05/2010 - 07/2007
1	Cerebral Palsy (Spastic Diplegia) 11/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Testicular Neoplasms (Testicular Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 05/2017 - 04/2002
10	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 08/2002
8	Transcription Factors (Transcription Factor)IBA 05/2017 - 01/2003
8	Polypeptide N-acetylgalactosaminyltransferaseIBA 01/2016 - 04/2002
7	mitochondrial transcription factor AIBA 01/2018 - 04/2010
7	ErbB Receptors (EGF Receptor)IBA 09/2012 - 07/2004
6	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 03/2002
6	Peptides (Polypeptides)IBA 01/2017 - 04/2002
6	Pharmaceutical PreparationsIBA 01/2017 - 03/2002
5	Biomarkers (Surrogate Marker)IBA 04/2021 - 02/2011
5	Small Interfering RNA (siRNA)IBA 04/2015 - 03/2010
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 06/2009
4	PeroxiredoxinsIBA 12/2019 - 10/2008
4	Indicators and Reagents (Reagents)IBA 01/2017 - 04/2002
4	Y-Box-Binding Protein 1IBA 06/2016 - 11/2004
4	ChemokinesIBA 01/2016 - 12/2007
4	AntioxidantsIBA 01/2016 - 10/2008
4	ParaffinIBA 01/2016 - 04/2002
4	CytokinesIBA 01/2016 - 12/2007
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2015 - 07/2007
4	Gefitinib (Iressa)FDA Link 03/2015 - 07/2007
4	GalactosamineIBA 02/2007 - 04/2002
4	Uridine Diphosphate (UDP)IBA 02/2007 - 04/2002
3	dectin 1IBA 02/2021 - 06/2016
3	Matrix Metalloproteinases (MMPs)IBA 10/2017 - 01/2009
3	DNA (Deoxyribonucleic Acid)IBA 12/2014 - 07/2010
3	Phosphotransferases (Kinase)IBA 08/2014 - 06/2009
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2012 - 03/2002
3	NF-kappa B (NF-kB)IBA 05/2010 - 12/2007
3	Biological ProductsIBA 01/2008 - 12/2003
2	titanium dioxide (Titania)FDA Link 01/2022 - 01/2015
2	PolymersIBA 01/2022 - 01/2021
2	acrylic acid (acrylate)IBA 01/2022 - 01/2021
2	Organic Chemicals (Chemicals, Organic)IBA 01/2022 - 01/2021
2	Complementary DNA (cDNA)IBA 02/2021 - 04/2015
2	Carrier Proteins (Binding Protein)IBA 01/2021 - 01/2020
2	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2020 - 01/2017
2	Polysaccharides (Glycans)IBA 01/2017 - 06/2016
2	Estrogen ReceptorsIBA 01/2017 - 05/2012
2	EnzymesIBA 01/2017 - 12/2014
2	MucinsIBA 01/2017 - 04/2002
2	UDP-N-acetylgalactosamine polypeptide N-acetylgalactosaminyltransferase 6IBA 01/2017 - 01/2017
2	Heme Oxygenase-1IBA 01/2016 - 01/2014
2	PlatinumIBA 08/2015 - 01/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2015 - 12/2005
2	Fluorouracil (Carac)FDA LinkGeneric 04/2015 - 03/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2015 - 12/2014
2	Adenosine Triphosphate (ATP)IBA 04/2015 - 01/2003
2	SurvivinIBA 02/2015 - 04/2011
2	HMGB1 Protein (HMG1)IBA 10/2014 - 01/2008
2	matrigelIBA 01/2014 - 08/2013
2	InterleukinsIBA 01/2014 - 12/2007
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2013 - 12/2007
2	CXC ChemokinesIBA 08/2013 - 05/2010
2	Messenger RNA (mRNA)IBA 09/2012 - 08/2002
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2011 - 02/2011
2	NF-KappaB Inhibitor alphaIBA 05/2010 - 06/2009
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2005 - 11/2004
1	Therapeutic UsesIBA 11/2022
1	OvalbuminIBA 01/2022
1	Serpentine Asbestos (Chrysotile)IBA 01/2022
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2022
1	AsbestosIBA 01/2022
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 04/2021
1	Protein Isoforms (Isoforms)IBA 02/2021
1	AntigensIBA 01/2021

Therapy/Procedure

11	Therapeutics 01/2020 - 01/2003
5	Drug Therapy (Chemotherapy) 01/2020 - 03/2002
2	Aftercare (After-Treatment) 10/2008 - 12/2005
1	Humidifiers 01/2021